<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Critical Appraisal: ADHD Drug Treatment and Risk Outcomes</title>
    <link rel="stylesheet" href="styles.css">
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0/css/all.min.css" rel="stylesheet">
</head>
<body>
    <header class="header">
        <div class="container">
            <h1>Critical Appraisal</h1>
            <h2>ADHD Drug Treatment and Risk of Suicidal Behaviours, Substance Misuse, Accidental Injuries, Transport Accidents, and Criminality</h2>
            <p class="subtitle">Emulation of Target Trials - BMJ 2025</p>
        </div>
    </header>

    <nav class="navigation">
        <div class="container">
            <ul class="nav-list">
                <li><a href="#overview">Overview</a></li>
                <li><a href="#methodology">Methodology</a></li>
                <li><a href="#results">Results</a></li>
                <li><a href="#bias-assessment">Bias Assessment</a></li>
                <li><a href="#clinical-implications">Clinical Implications</a></li>
                <li><a href="#limitations">Limitations</a></li>
                <li><a href="#conclusion">Conclusion</a></li>
            </ul>
        </div>
    </nav>

    <main class="main-content">
        <div class="container">
            <section id="overview" class="section">
                <h2><i class="fas fa-clipboard-list"></i> Study Overview</h2>
                <div class="study-info">
                    <div class="info-card">
                        <h3>Authors</h3>
                        <p>Le Zhang, Nanbo Zhu, Arvid Sj√∂lander, et al.</p>
                    </div>
                    <div class="info-card">
                        <h3>Journal</h3>
                        <p>BMJ 2025;390:e083658</p>
                    </div>
                    <div class="info-card">
                        <h3>Study Design</h3>
                        <p>Target Trial Emulation using Swedish National Registers</p>
                    </div>
                    <div class="info-card">
                        <h3>Sample Size</h3>
                        <p>148,581 individuals with ADHD diagnosis</p>
                    </div>
                </div>
                
                <div class="key-findings">
                    <h3>Key Findings</h3>
                    <div class="findings-grid">
                        <div class="finding positive">
                            <i class="fas fa-check-circle"></i>
                            <h4>Suicidal Behaviours</h4>
                            <p>17% reduction (IRR: 0.83, 95% CI: 0.78-0.88)</p>
                        </div>
                        <div class="finding positive">
                            <i class="fas fa-check-circle"></i>
                            <h4>Substance Misuse</h4>
                            <p>15% reduction (IRR: 0.85, 95% CI: 0.83-0.87)</p>
                        </div>
                        <div class="finding neutral">
                            <i class="fas fa-minus-circle"></i>
                            <h4>Accidental Injuries</h4>
                            <p>No significant reduction (IRR: 0.98, 95% CI: 0.96-1.01)</p>
                        </div>
                        <div class="finding positive">
                            <i class="fas fa-check-circle"></i>
                            <h4>Transport Accidents</h4>
                            <p>12% reduction (IRR: 0.88, 95% CI: 0.82-0.94)</p>
                        </div>
                        <div class="finding positive">
                            <i class="fas fa-check-circle"></i>
                            <h4>Criminality</h4>
                            <p>13% reduction (IRR: 0.87, 95% CI: 0.83-0.90)</p>
                        </div>
                    </div>
                </div>
            </section>

            <section id="methodology" class="section">
                <h2><i class="fas fa-microscope"></i> Methodology Assessment</h2>
                
                <div class="methodology-grid">
                    <div class="method-card">
                        <h3><i class="fas fa-chart-line"></i> Study Design Strengths</h3>
                        <ul>
                            <li><i class="fas fa-plus"></i> Target trial emulation framework</li>
                            <li><i class="fas fa-plus"></i> Large population-based sample</li>
                            <li><i class="fas fa-plus"></i> Comprehensive Swedish register data</li>
                            <li><i class="fas fa-plus"></i> Cloning, censoring, and weighting approach</li>
                            <li><i class="fas fa-plus"></i> Pre-registered study protocol</li>
                        </ul>
                    </div>
                    
                    <div class="method-card">
                        <h3><i class="fas fa-users"></i> Population & Selection</h3>
                        <ul>
                            <li><i class="fas fa-plus"></i> Broad age range (6-64 years)</li>
                            <li><i class="fas fa-plus"></i> Incident ADHD diagnoses only</li>
                            <li><i class="fas fa-plus"></i> 18-month washout period</li>
                            <li><i class="fas fa-plus"></i> Representative of clinical practice</li>
                            <li><i class="fas fa-minus"></i> Excluded prevalent users only</li>
                        </ul>
                    </div>
                    
                    <div class="method-card">
                        <h3><i class="fas fa-cogs"></i> Statistical Methods</h3>
                        <ul>
                            <li><i class="fas fa-plus"></i> Inverse probability weighting</li>
                            <li><i class="fas fa-plus"></i> Time-varying covariates</li>
                            <li><i class="fas fa-plus"></i> Bootstrap confidence intervals</li>
                            <li><i class="fas fa-plus"></i> Sensitivity analyses</li>
                            <li><i class="fas fa-plus"></i> Negative control analysis</li>
                        </ul>
                    </div>
                </div>
            </section>

            <section id="results" class="section">
                <h2><i class="fas fa-chart-bar"></i> Results Summary</h2>
                
                <div class="results-container">
                    <div class="results-table">
                        <h3>Primary Outcomes - First Events</h3>
                        <table>
                            <thead>
                                <tr>
                                    <th>Outcome</th>
                                    <th>Treatment Group Rate</th>
                                    <th>Control Group Rate</th>
                                    <th>Incidence Rate Ratio</th>
                                    <th>95% CI</th>
                                    <th>Significance</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr class="significant">
                                    <td>Suicidal Behaviours</td>
                                    <td>14.5/1000 PY</td>
                                    <td>16.9/1000 PY</td>
                                    <td>0.83</td>
                                    <td>0.78-0.88</td>
                                    <td><i class="fas fa-check text-green"></i></td>
                                </tr>
                                <tr class="significant">
                                    <td>Substance Misuse</td>
                                    <td>58.7/1000 PY</td>
                                    <td>69.1/1000 PY</td>
                                    <td>0.85</td>
                                    <td>0.83-0.87</td>
                                    <td><i class="fas fa-check text-green"></i></td>
                                </tr>
                                <tr class="non-significant">
                                    <td>Accidental Injuries</td>
                                    <td>88.5/1000 PY</td>
                                    <td>90.1/1000 PY</td>
                                    <td>0.98</td>
                                    <td>0.96-1.01</td>
                                    <td><i class="fas fa-times text-red"></i></td>
                                </tr>
                                <tr class="significant">
                                    <td>Transport Accidents</td>
                                    <td>24.0/1000 PY</td>
                                    <td>27.5/1000 PY</td>
                                    <td>0.88</td>
                                    <td>0.82-0.94</td>
                                    <td><i class="fas fa-check text-green"></i></td>
                                </tr>
                                <tr class="significant">
                                    <td>Criminality</td>
                                    <td>65.1/1000 PY</td>
                                    <td>76.1/1000 PY</td>
                                    <td>0.87</td>
                                    <td>0.83-0.90</td>
                                    <td><i class="fas fa-check text-green"></i></td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                    
                    <div class="recurrent-events">
                        <h3>Recurrent Events Analysis</h3>
                        <p>All five outcomes showed statistically significant reductions in recurrent events, with incidence rate ratios ranging from 0.75 to 0.96, suggesting sustained benefits of treatment.</p>
                    </div>
                </div>
            </section>

            <section id="bias-assessment" class="section">
                <h2><i class="fas fa-balance-scale"></i> Bias Assessment</h2>
                
                <div class="bias-grid">
                    <div class="bias-card low-risk">
                        <h3><i class="fas fa-shield-alt"></i> Low Risk of Bias</h3>
                        <ul>
                            <li><strong>Selection Bias:</strong> Minimized through target trial emulation</li>
                            <li><strong>Information Bias:</strong> High-quality register data with good validity</li>
                            <li><strong>Confounding:</strong> Extensive covariate adjustment and IPW</li>
                            <li><strong>Attrition Bias:</strong> Complete follow-up through registers</li>
                        </ul>
                    </div>
                    
                    <div class="bias-card moderate-risk">
                        <h3><i class="fas fa-exclamation-triangle"></i> Moderate Risk of Bias</h3>
                        <ul>
                            <li><strong>Residual Confounding:</strong> Unmeasured factors (ADHD severity, lifestyle)</li>
                            <li><strong>Exposure Misclassification:</strong> Dispensed vs. consumed medication</li>
                            <li><strong>Outcome Misclassification:</strong> Underreporting of less severe events</li>
                            <li><strong>Time-varying Confounding:</strong> Despite IPW, some bias may remain</li>
                        </ul>
                    </div>
                    
                    <div class="bias-card">
                        <h3><i class="fas fa-search"></i> Bias Mitigation Strategies</h3>
                        <ul>
                            <li>Negative control analysis (Type 1 diabetes)</li>
                            <li>Sensitivity analyses with extended grace periods</li>
                            <li>Subgroup analyses by history of events</li>
                            <li>Comparison of stimulants vs. non-stimulants</li>
                        </ul>
                    </div>
                </div>
            </section>

            <section id="clinical-implications" class="section">
                <h2><i class="fas fa-stethoscope"></i> Clinical Implications</h2>
                
                <div class="implications-grid">
                    <div class="implication-card">
                        <h3><i class="fas fa-heart"></i> Patient Benefits</h3>
                        <ul>
                            <li>Reduced risk of self-harm and suicide</li>
                            <li>Lower substance misuse rates</li>
                            <li>Decreased criminal involvement</li>
                            <li>Fewer transport accidents</li>
                            <li>Particularly beneficial for high-risk patients</li>
                        </ul>
                    </div>
                    
                    <div class="implication-card">
                        <h3><i class="fas fa-prescription-bottle"></i> Treatment Decisions</h3>
                        <ul>
                            <li>Stimulants more effective than non-stimulants</li>
                            <li>Consider treatment for patients with previous events</li>
                            <li>Benefits extend beyond core ADHD symptoms</li>
                            <li>Long-term treatment may be necessary</li>
                            <li>Individual risk-benefit assessment crucial</li>
                        </ul>
                    </div>
                    
                    <div class="implication-card">
                        <h3><i class="fas fa-chart-line"></i> Public Health Impact</h3>
                        <ul>
                            <li>Potential reduction in healthcare costs</li>
                            <li>Decreased criminal justice system burden</li>
                            <li>Improved quality of life for patients</li>
                            <li>Support for WHO essential medicines list inclusion</li>
                            <li>Evidence for policy makers and guidelines</li>
                        </ul>
                    </div>
                </div>
            </section>

            <section id="limitations" class="section">
                <h2><i class="fas fa-exclamation-circle"></i> Study Limitations</h2>
                
                <div class="limitations-grid">
                    <div class="limitation-card">
                        <h3><i class="fas fa-database"></i> Data Limitations</h3>
                        <ul>
                            <li>No data on non-drug treatments</li>
                            <li>Dispensed vs. consumed medication</li>
                            <li>Missing dosage information</li>
                            <li>Limited capture of mild outcomes</li>
                            <li>No ADHD subtype information</li>
                        </ul>
                    </div>
                    
                    <div class="limitation-card">
                        <h3><i class="fas fa-globe"></i> Generalizability</h3>
                        <ul>
                            <li>Swedish healthcare system specific</li>
                            <li>88.4% started with methylphenidate</li>
                            <li>Different prescribing practices elsewhere</li>
                            <li>Cultural and legal system differences</li>
                            <li>Limited ethnic diversity</li>
                        </ul>
                    </div>
                    
                    <div class="limitation-card">
                        <h3><i class="fas fa-cogs"></i> Methodological Concerns</h3>
                        <ul>
                            <li>Residual confounding possible</li>
                            <li>Time-varying confounding challenges</li>
                            <li>Per-protocol analysis limitations</li>
                            <li>Smaller effect sizes than previous studies</li>
                            <li>Potential selection bias in treatment initiation</li>
                        </ul>
                    </div>
                </div>
            </section>

            <section id="conclusion" class="section">
                <h2><i class="fas fa-gavel"></i> Critical Appraisal Conclusion</h2>
                
                <div class="conclusion-content">
                    <div class="overall-assessment">
                        <h3>Overall Assessment</h3>
                        <div class="assessment-score">
                            <div class="score-item">
                                <span class="label">Study Quality:</span>
                                <div class="stars">
                                    <i class="fas fa-star"></i>
                                    <i class="fas fa-star"></i>
                                    <i class="fas fa-star"></i>
                                    <i class="fas fa-star"></i>
                                    <i class="far fa-star"></i>
                                </div>
                            </div>
                            <div class="score-item">
                                <span class="label">Clinical Relevance:</span>
                                <div class="stars">
                                    <i class="fas fa-star"></i>
                                    <i class="fas fa-star"></i>
                                    <i class="fas fa-star"></i>
                                    <i class="fas fa-star"></i>
                                    <i class="fas fa-star"></i>
                                </div>
                            </div>
                            <div class="score-item">
                                <span class="label">Generalizability:</span>
                                <div class="stars">
                                    <i class="fas fa-star"></i>
                                    <i class="fas fa-star"></i>
                                    <i class="fas fa-star"></i>
                                    <i class="far fa-star"></i>
                                    <i class="far fa-star"></i>
                                </div>
                            </div>
                        </div>
                    </div>
                    
                    <div class="key-takeaways">
                        <h3>Key Takeaways</h3>
                        <div class="takeaway-grid">
                            <div class="takeaway positive">
                                <i class="fas fa-thumbs-up"></i>
                                <h4>Strengths</h4>
                                <ul>
                                    <li>Robust methodology with target trial emulation</li>
                                    <li>Large, representative population sample</li>
                                    <li>Comprehensive outcome assessment</li>
                                    <li>Multiple sensitivity analyses</li>
                                    <li>Clinically relevant findings</li>
                                </ul>
                            </div>
                            <div class="takeaway caution">
                                <i class="fas fa-exclamation-triangle"></i>
                                <h4>Cautions</h4>
                                <ul>
                                    <li>Observational study design limitations</li>
                                    <li>Potential residual confounding</li>
                                    <li>Limited generalizability beyond Sweden</li>
                                    <li>No information on non-drug treatments</li>
                                    <li>Smaller effect sizes than expected</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                    
                    <div class="final-recommendation">
                        <h3>Final Recommendation</h3>
                        <p>This study provides valuable evidence supporting the benefits of ADHD drug treatment on important clinical outcomes beyond core symptoms. The target trial emulation design represents a methodological advance in pharmacoepidemiology. While the findings are encouraging, clinicians should consider the study limitations and individual patient factors when making treatment decisions. The evidence supports continued use of ADHD medications, particularly stimulants, in appropriate patients, while acknowledging the need for ongoing monitoring and comprehensive care approaches.</p>
                    </div>
                </div>
            </section>
        </div>
    </main>

    <footer class="footer">
        <div class="container">
            <p>&copy; 2025 Critical Appraisal Tool. This is an educational resource for medical professionals.</p>
            <p><strong>Disclaimer:</strong> This critical appraisal is for educational purposes only and should not replace clinical judgment or professional medical advice.</p>
        </div>
    </footer>

    <script src="script.js"></script>
</body>
</html>